Efficacy Of Hiatal Closure For GERD
ConditionGastro Esophageal Reflux
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-50
SponsorUniversity of Chicago
About this trial
The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 - 50 years
Able to provide informed consent
BMI <30
Hiatal defect <4cm on esophagram
Disqualifiers
Vulnerable subjects (children, prisoners, pregnant women) will be excluded.
Trial population
The estimated annual number of subjects enrolled prospectively in the study is 20. The recruitment goal is 40. The research team will screen all patients that are being followed-up at the gastrointestinal surgery clinic at the UCM.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Concentration of pH testing
Determine GERD remission for hiatal closure alone for patients with pH proven GERD
Time frame
at 1 and 2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov